Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Future treatments for hair loss may focus on personalized and regenerative approaches.

Apigenin may effectively promote hair growth for androgenetic alopecia when applied topically.

PRP therapy helps improve hair growth and is safe for treating hair loss.

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

Cathelicidins could treat skin issues but face challenges like safety and resistance.

Beetroot extract nanogel may help treat hair loss caused by testosterone.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Targeting senescent cells may offer new treatments for PCOS.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Hair restoration techniques have improved but still rely on limited donor hair, with new methods like cloning and gene therapy being explored.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

More personalized and effective treatments for androgenetic alopecia are needed.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Testosterone affects vascular cells directly without converting to estradiol.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Androgenetic alopecia in PCOS is linked to insulin resistance, inflammation, and genetics, not just hormones.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

More research is needed to understand how testosterone is maintained in adult males.

Hirsutism is when women have too much hair growth, often due to a bit more androgen hormones and sensitive skin.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.